100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
systematic anticancer therapy part 2 £7.49   Add to cart

Lecture notes

systematic anticancer therapy part 2

 7 views  0 purchase

part 2 includes: points of intervention, EGFR, Chromosome 2, second generation ALK inhibitors, the role of the immune system, how the drugs work

Preview 1 out of 3  pages

  • December 21, 2023
  • 3
  • 2021/2022
  • Lecture notes
  • Mike lynn
  • All classes
All documents for this subject (31)
avatar-seller
lauryndavison
1
Wednesday, 27/10/2021
Week 5
Lecture
Prof. Mike Lynn

Systemic Anticancer Therapy
Part Two
 By the late 1980s it became apparent that cytotoxic therapy had reached the glass
ceiling
 Not going to produce the gains required
 Progress came from studying the cancer cells in depth
Possible points of intervention
 Complexities around this
 All cells have receptors which have an extra/trans/intra cellular domains
 Phosphorylation
 Sets off a cascade of signals
 Leads to increased proliferation
 BRAF inhibitors come to the fore in melanomas
 In many cancers components of cell signal pathways don’t require a stimulus
EGFR
 Epidermal growth factor receptor
 Found in embryonic growth
 Later found it was present in many cancer cells especially in the lungs
 When these drugs were taken into the European population they didn’t work while
they had in Japan
 Patients who did well had never smoked, were of eastern or Asian origin and were
female
 Due to a mutation
 In an area called the ATP binding cassette this process is short circuited, and the ATP
is bound tightly
 The drugs competitively inhibit the binding of ATP
 EGFR mutation status the response rate to gefitinib was very high
 High rates of survival
 Many patients become resistant due to a mutation on the EXON20
 Now a third generation called Osimertinib
 Given to those who have relapsed
 Those shown to have the mutation do much better with this also
Chromosome 2 – EML4 and ALK
 EML4 gene is inverted through 180 and stuck by the ALK gene – found in lung
cancers
 Many ways to diagnose
o FISH
o PCR/Sequencing
o Using dyes
Does it work?
 Study looked at no treatment and locally advanced non-small cell lung cancer
 Very common to see brain metastases
 Randomised crizotinib or chemotherapy
 Medium duration of treatment was longer with crizotinib

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller lauryndavison. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £7.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73918 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£7.49
  • (0)
  Add to cart